Antibodies, Anti-Actin, Anti-Smooth Muscle
NJF is the FDA product code for Antibodies, Anti-Actin, Anti-Smooth Muscle, a class II device type, regulated under 21 CFR 866.5120. FDA's definition for this code reads: "The device is used for the semi-quantitative detection of IgG antibodies to the actin component of smooth muscle in human serum as an aid in the diagnosis of certain autoimmune liver diseases, e.g. autoimmune hepatitis". As of , FDA records hold one 510(k) clearance under this code, the most recent dated , and no recalls.
Classification record
- Product code
- NJF
- Device name
- Antibodies, Anti-Actin, Anti-Smooth Muscle
- FDA definition
- The device is used for the semi-quantitative detection of IgG antibodies to the actin component of smooth muscle in human serum as an aid in the diagnosis of certain autoimmune liver diseases, e.g. autoimmune hepatitis.
- Regulation
- 21 CFR 866.5120
- Device class
- Class II
- Review panel
- Immunology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 1
- Ingested recalls
- 0
Clearances, product code NJF
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2002 | 1 |
Applicants with the most clearances
Product code NJF| Applicant | Clearances |
|---|---|
| Inova Diagnostics, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
